Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | aspartyl aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Loa Loa (eye worm) | aspartyl aminopeptidase | 0.0076 | 0.3769 | 0.7332 |
Trypanosoma cruzi | metallo-peptidase, Clan MH, Family M20 | 0.0076 | 0.3769 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.0808 | 0.1571 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.0808 | 0.1571 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.0808 | 0.1571 |
Onchocerca volvulus | 0.0028 | 0.0808 | 0.5 | |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0099 | 0.5141 | 1 |
Mycobacterium tuberculosis | Probable aminopeptidase PepC | 0.0076 | 0.3769 | 0.5 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0076 | 0.3769 | 1 |
Entamoeba histolytica | aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0076 | 0.3769 | 0.3222 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0099 | 0.5141 | 0.4714 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0099 | 0.5141 | 0.4714 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.3769 | 0.7332 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.3769 | 0.7332 |
Brugia malayi | Aspartyl aminopeptidase | 0.0076 | 0.3769 | 0.7332 |
Schistosoma mansoni | aspartyl aminopeptidase (M18 family) | 0.0076 | 0.3769 | 0.3222 |
Schistosoma mansoni | hypothetical protein | 0.0178 | 1 | 1 |
Echinococcus multilocularis | aspartyl aminopeptidase | 0.0076 | 0.3769 | 0.3222 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0076 | 0.3769 | 1 |
Entamoeba histolytica | aspartyl aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.0808 | 0.1571 |
Plasmodium falciparum | M18 aspartyl aminopeptidase | 0.0076 | 0.3769 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0099 | 0.5141 | 0.4714 |
Trypanosoma brucei | aspartyl aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Leishmania major | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 | 0.0076 | 0.3769 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0776 | 0.1509 |
Plasmodium vivax | M18 aspartyl aminopeptidase, putative | 0.0076 | 0.3769 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.5141 | 0.4714 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0808 | 0.1571 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0099 | 0.5141 | 1 |
Trichomonas vaginalis | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase | 0.0076 | 0.3769 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.5141 | 0.4714 |
Schistosoma mansoni | hypothetical protein | 0.0178 | 1 | 1 |
Echinococcus granulosus | aspartyl aminopeptidase | 0.0076 | 0.3769 | 0.3222 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.5141 | 0.4714 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0099 | 0.5141 | 0.4714 |
Onchocerca volvulus | 0.0028 | 0.0808 | 0.5 | |
Mycobacterium leprae | PROBABLE AMINOPEPTIDASE PEPC | 0.0076 | 0.3769 | 0.5 |
Echinococcus multilocularis | geminin | 0.0178 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.